The elevated, tumor-specific response of CD4+ and CD8+ T cells in HCC patients following ablation and the spontaneous regression of untreated (distant) as well as ablated primary tumors in animal models suggest that ablation elicits a systemic, albeit not curative, anti-tumor response [19,20]. Here, CD8A is linked to hepatocellular carcinoma.